A Phase 1 Open Label, Randomized Clinical Trial Assessing Safety of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women.

Trial Profile

A Phase 1 Open Label, Randomized Clinical Trial Assessing Safety of MF101 for Hot Flushes and Menopausal Symptoms in Postmenopausal Women.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2011

At a glance

  • Drugs MF 101 (Primary)
  • Indications Hot flashes
  • Focus Adverse reactions
  • Most Recent Events

    • 30 Aug 2011 Patient numbers are 35 (actual), as reported in the Bionova media release.
    • 30 Aug 2011 Status changed from active, no longer recruiting to completed, as reported in a Bionovo media release.
    • 26 May 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top